Approval · Notice of Compliance 27173 · 2021
FLUVOXAMINE: Notice of Compliance 27173
Issued December 6, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 27173
- Date
- December 6, 2021
- Company
- Apotex Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Update to the product monograph
- Canadian reference product
- LUVOX (Solvay Kingswood Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FLUVOXAMINE | Not yet assigned | — |
Medicinal ingredients
- FLUVOXAMINE MALEATE 50 MG per TAB
- FLUVOXAMINE MALEATE 100 MG per TAB